Correlation of Tractography and Motor Evoked Potentials in Deep Brain Stimulation

NCT ID: NCT03136302

Last Updated: 2024-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-09-01

Study Completion Date

2025-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal is to establish another anatomical referencing system in order to achieve an even higher accuracy when implanting stimulation electrodes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main goal is to find out what are the optimal distances to these reference fiber tracts when stimulating and to find the optimal target. This has to be evaluated for each target, such as globus pallidus (Gpi), subthalamic nucleus (STN) and ventral intermediate nucleus of the thalamus (VIM) separately. This is of special importance as the investigators can demonstrate the internal capsule, which is often a generator of stimulation-induced side effects: tetanic muscle contractions, dysarthria and gaze deviations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Improving Accuracy of Implanting Stimulation Electrodes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subthalamic Nucleus (STN)

Patients with Parkinson's disease

Deep Brain Stimulation

Intervention Type PROCEDURE

Deep Brain Stimulation

Globus Pallidus (Gpi)

Patients with Dystonia

Deep Brain Stimulation

Intervention Type PROCEDURE

Deep Brain Stimulation

Ventral intermediate nucleus of the thalamus (VIM)

Patients with Tremor

Deep Brain Stimulation

Intervention Type PROCEDURE

Deep Brain Stimulation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Deep Brain Stimulation

Deep Brain Stimulation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient qualifying for deep brain stimulation on the basis of a movement disorder (Parkinson's Disease, tremor, dystonia) or chronic pain disease.
* Informed consent

Exclusion Criteria

* Lack of consent
* Electrical or other devices that preclude the performance of an MRI
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nova Scotia Health Authority

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lutz Weise, MD

Role: PRINCIPAL_INVESTIGATOR

Dalhousie University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Queen Elizabeth Health Science Centre

Halifax, Nova Scotia, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lutz Weise, MD

Role: CONTACT

902-473-6850

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lutz Weise, MD

Role: primary

902-473-6850

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DBS2017

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Non-Invasive Brain Stimulation
NCT04318522 UNKNOWN NA